Related Experiment Video
Updated: Jun 10, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it
Carmen Chak-Lui Wong1, Chun-Ming Wong, Sandy Leung-Kuen Au
1Liver Cancer and Hepatitis Research Laboratory, Department of Pathology, University of Hong Kong, Pokfulam, Hong Kong.
Insights
Hepatocellular carcinoma (HCC) metastasis is a major cause of death. Targeting the RhoGTPases/Rho-effector pathway, crucial for cell movement, offers potential new therapies for advanced liver cancer.
Area of Science:
- Oncology
- Cell Biology
- Molecular Signaling
Background:
- Hepatocellular carcinoma (HCC) presents a significant global health challenge due to its high mortality rate.
- Tumor metastasis is the primary driver of liver failure, recurrence, and mortality in HCC patients.
- Current therapeutic options for advanced HCC and its metastasis remain limited and largely ineffective.
Purpose of the Study:
- To review the fundamental mechanisms of cancer metastasis and cell migration, with a specific emphasis on HCC.
- To elucidate the role of the RhoGTPases/Rho-effector pathway in mediating HCC metastasis.
- To explore potential therapeutic strategies targeting this pathway for HCC treatment.
Main Methods:
- Literature review focusing on cancer metastasis, cell movement, and the RhoGTPases/Rho-effector signaling pathway.
- Analysis of upstream regulators, RhoGTPases, Rho-effectors, and their downstream targets in the context of HCC metastasis.
- Discussion of therapeutic implications derived from understanding this signaling cascade.
Main Results:
- The RhoGTPases/Rho-effector pathway is critically involved in orchestrating cytoskeletal reorganization, a key process in HCC cell migration and metastasis.
- Specific RhoGTPases and their effectors play significant roles in the metastatic cascade of hepatocellular carcinoma.
- Understanding the intricate signaling network of RhoGTPases/Rho-effectors is vital for developing effective anti-metastatic therapies.
Conclusions:
- The RhoGTPases/Rho-effector signaling pathway is a pivotal regulator of HCC metastasis.
- Targeting this pathway holds promise for developing novel therapeutic interventions against advanced HCC.
- Further in-depth research into this complex signaling network is necessary to translate findings into clinical applications.
Abstract:
Hepatocellular carcinoma (HCC) is an intractable disease with an extremely high mortality rate. Metastasis is the major factor of liver failure, tumour recurrence and death in HCC patients. Unfortunately, no promising curative therapy for HCC metastasis is available as yet; therefore, treatment for advanced HCC still remains a formidable challenge. A large body of evidence has demonstrated that the RhoGTPases/Rho-effector pathway plays important roles in mediating HCC metastasis based on their foremost functions in orchestrating the cell cytoskeletal reorganization. This review will first discuss the general principles of cancer metastasis and cancer cell movement with a particular focus on HCC.We will then summarize the implications of various members in the RhoGTPases/Rho-effectors signalling cascade including the upstream RhoGTPase regulators RhoGTPases and Rho-effectors and their downstream targets in HCC metastasis. Finally, we will discuss the therapeutic insight of targeting the RhoGTPases/Rho-effector pathway in HCC. Taken together, the literature demonstrates the importance of the RhoGTPases/Rho-effector signalling pathway in HCC metastasis and marks the necessity to have a more thorough knowledge of this complicated signalling network in order to develop novel therapeutic strategies for HCC patients.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
The Ras Gene
Ras is a superfamily...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytoskeletal Coordination in Cell Migration
Cancer Cell Migration through Invadopodia